Drug Induced Lupus Erythematosus Due to Capecitabine and Bevacizumab Treatment Presenting with Prolonged Thrombocytopenia

1. REEFMAN E, KUİPER H, JONKMAN MF, et al. Skin sensitivity to UVB irradiation in systemic lupus erythematosus is not related to the level of apoptosis induction in keratinocytes. Rheumatology. 2006; 45:538-44.10.1093/rheumatology/kei24916352635Search in Google Scholar

2. SARZİ-PUTTİNİ P, ATZENİ F, CAPSONİ F, et al. Drug induced lupus erythematosus. Autoimmunity. 2005; 38:507-18.10.1080/0891693050028585716373256Search in Google Scholar

3. MARZANO AV, VEZZOLİ P, CROSTİ C. Drug-induced lupus: an update on its dermatologic aspects. Lupus. 2009; 18:935-40.10.1177/096120330910617619762393Search in Google Scholar

4. KATZ U, ZANDMAN-GODDARD G. Drug-induced lupus: an update. Autoimmun Rev. 2010; 10:46-50.10.1016/j.autrev.2010.07.00520656071Search in Google Scholar

5. KİNDEM S, LLOMBART B, REQUENA C, et al. Subacute cutaneous lupus erythematosus after treatment with capecitabine. J Dermatol. 2013; 40:75-6.10.1111/j.1346-8138.2012.01646.x22937906Search in Google Scholar

6. FERNANDES NF, ROSENBACH M, ELENİTSAS R, KİST JM. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy. Arch Dermatol. 2009; 145:340-1.10.1001/archdermatol.2008.61919289781Search in Google Scholar

7. KO JH, HSİEH CI, CHOU CY, WANG KH. Capecitabine-induced subacute cutaneous lupus erythematosus: report of a case with positive rechallenge test. J Dermatol. 2013; 40:939-40.10.1111/1346-8138.1228124111883Search in Google Scholar

8. WEGER W, KRÄNKE B, GERGER A, et al. Occurrence of subacute cutaneous lupus erythematosusafter treatment with fluorouracil and capecitabine. J Am Acad Dermatol. 2008; 59:4-6.10.1016/j.jaad.2007.06.04018625380Search in Google Scholar

9. FLORİSTAN U, FELTES RA, SENDAGORTA E, et al. Subacute cutaneous lupus erythematosus induced by capecitabine. Clin Exp Dermatol. 2009; 34:328-9.10.1111/j.1365-2230.2009.03280.x19456774Search in Google Scholar

10. WİESENTHAL A, MATHERNE R, GİBSON B. Capecitabine-induced systemic lupuserythematosus and palmoplantar erythrodysesthesia. J Drugs Dermatol. 2012; 11:769-71.Search in Google Scholar

11. MERLİN F, PROCHİLO T, KİLDANİ B, et al. Discoid lupus erythematosus (DLE)-like lesions induced by capecitabine. Int J Colorectal Dis. 2008; 23:715-6.10.1007/s00384-008-0462-818330579Search in Google Scholar

12. VİHİNEN P, PAİJA O, KİVİSAARİ A, et al. Cutaneous lupus erythematosus after treatment with paclitaxel and bevacizumab for metastatic breast cancer: a case report. J Med Case Rep. 2011; 5:243.10.1186/1752-1947-5-243314310121707979Search in Google Scholar

13. DUDLEY K, MİCETİCH K, MASSA MC. Erythema with features of seborrheic dermatitis and lupus erythematosus associated with systemic 5-fluorouracil. Cutis. 1987; 39:64-6.Search in Google Scholar

14. KLUGER N, BESSİS D, GUİLLOT B. Chronic cutaneous lupus flare induced by systemic 5-fluorouracil. J Dermatolog Treat. 2006; 17:51-3.10.1080/0954663050047559116467025Search in Google Scholar

15. MOAZZAM N, MALİK AA, MEHDİ SA, POTTİ A. Treatment side effects. Case 3. Fluorouracil-induced exacerbation of systemic lupus erythematosus. J Clin Oncol. 2002; 20:3032-4.10.1200/JCO.2002.20.13.303212089235Search in Google Scholar

16. YOSHİMASU T, HİROİ A, UEDE K, FURUKAWA F. Discoid lupus erythematosus (DLE)-like lesion induced by uraciltegafur (UFT). Eur J Dermatol. 2001; 11:54-7.Search in Google Scholar

17. ALMAGRO BM, STEYLS MC, NAVARRO NL, et al. Occurrence of subacute cutaneous lupus erythematosus after treatment with systemic fluorouracil. J Clin Oncol. 2011; 29:613-5.10.1200/JCO.2011.35.068621537030Search in Google Scholar